Incremental costs of chemotherapy – Pharmacoeconomic results from the prospective adjuvant WSG-AGO Intergroup EC-DOC trial comparing an anthracycline-docetaxel sequence to CMF in node-positive breast cancer
M. Braun, V.R. Jacobs, S. Wagenpfeil, D. Sattler, N. Harbeck, U. Nitz, R. Bernard, W. Kuhn, A. Ihbe-HeffingerVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70540-8
File:
PDF, 62 KB
english, 2008